Association of progesterone receptor status with 21-gene recurrence score and survival among patients with estrogen receptor-positive breast cancer

Abstract Background Progesterone receptor (PR)-negative tumors have been shown to have worse prognosis and were underrepresented in recent trials on patients with estrogen receptor (ER)-positive breast cancer. The role of PR-negative status in the context of 21-gene recurrence score (RS) and nodal s...

Celý popis

Podrobná bibliografie

Hlavní autoři:	Sung Jun Ma, Jasmin Gill, Keerti Yendamuri, Udit Chatterjee, Olivia Waldman, Cynthia Dunne-Jaffe, Fatemeh Fekrmandi, Rohil Shekher, Austin Iovoli, Song Yao, Oluwadamilola T. Oladeru, Anurag K. Singh
Médium:	Artigo
Jazyk:	Inglês
Vydáno:	BMC 2023-04-01
Edice:	BMC Cancer
Témata:	PR status Oncotype score Chemo Chemotherapy
On-line přístup:	https://doi.org/10.1186/s12885-023-10796-4
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!